founded date:
2015-09-01
bitcoin only:
No
market valuation:
$85.0 Million
web url:
ceo:
James Jungkue Lee
founders:
James Jungkue Lee
key leadership:
Kyu-Sik Yu (CFO)
lead investors:
KOSDAQ Equity Investors
total invested capital:
$60 Million
subsidiaries:
Bridge Bio USA Inc.
founder pedigree:
South Korean Medical & Biotech Scientists
btc holdings:
12 BTC
btc yield per share:
N/A
infra overview:
South Korean clinical-stage biotech company allocating corporate balance sheet reserves into Bitcoin for asset preservation.
primary business revenue:
Therapeutic Drug Development & Patent Licensing
revenue activities:
Out-Licensing & Milestone Payments
official email:
ir@bridgebiox.com
contact phone:
+82 31-628-0500
contact address:
Seongnam, South Korea
x handle: